Volver a Agenda
SESSION 2: International Collaboration & Regulatory Systems Strengthening
Session Chair(s)
Alia Seoud Abdalla
Global Regulatory Sciences Head (Africa Cluster)
Pfizer, Egypt
Samvel Azatyan, MD, PhD
Senior Adviser
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
SESSION 2: International Collaboration & Regulatory Systems Strengthening
Speaker(s)
Strengthening Regulatory Systems, EDA’s Milestone towards WHO GBT Maturity Level 3
Dalia Abou Hussein
Egyptian Drug Authority (EDA), Egypt
Quality Assurance (QA) General Director
Saudi FDA’s ML4 & WLA Journey
Bandar Al Hammad, MPharm
Saudi Food and Drug Authority (SFDA), Saudi Arabia
Chief Pharmacist & Director of Veterinary Preparations Department
Tunisia’s experience with Reliance and role in North Africa Harmonisation initiative
Sonia Sebai Ben Amor
Tunisian Medicines Agency (AEMPS), Tunisia
Head - National Control Laboratory National Regulatory Authority
Convergence and Harmonisation in Africa: AMA operationalisation progress, AMA continental pilot, Africa Continental Reliance Framework and North Africa Harmonisation initiative
Nancy Yang Ngum
African Union Development Agency (AUDA-NEPAD), South Africa
Public Health Officer (Public Health Expert)
Reliance Pilots - Industry experience with AMA continental pilot
Christine Ledimo
MSD , South Africa
Senior Director: Regulatory Affcairs SSA
Reliance Pilots - Industry experience with AMA continental pilot
Charlene Roopnarain
Merck Serono, South Africa
Regulatory Affairs Cluster Head - South Africa, Nigeria and East Africa
Panel Discussion with Q&A (With the additional participation of):
Enas Hijjih
Jordan Food and Drug Administration (JFDA), Jordan
Head of Bioequivalence Division- Registration department
¿Tiene una cuenta?